Bioanalytical method development and validation are at the forefront of ensuring rigorous, reproducible and reliable data in both drug development and clinical diagnostics. The field encompasses the ...

The unique ability of BsAbs to target two molecules and drive synergistic effects opens new options for refractory cancers and autoimmune diseases, potentially addressing numerous medical unmet needs.

Analytical performance should lead method decisions, but optimization can still reduce solvent, energy, and waste provided validation criteria and legislative requirements remain satisfied. Greenness ...